Sort
50,496 grants matching “lung cancer”
TGF-beta Suppression and Promotion of Mammary Carcinomas
$461,448Harold L Moses · Vanderbilt University · R01 · FY2011 · CA
Personalized radiation therapy through functional lung avoidance and response-adaptive dose escalation: utilizing multimodal molecular imaging to improve the therapeutic ratio
$461,368Stephen R. Bowen · University Of Washington · R01 · FY2017 · CA
Personalized radiation therapy through functional lung avoidance and response-adaptive dose escalation: utilizing multimodal molecular imaging to improve the therapeutic ratio
$461,368Stephen R. Bowen · University Of Washington · R01 · FY2018 · CA
Targeting UHRF1 in combinational immunotherapy
$461,315Xiao-Fan Wang · Duke University · R01 · FY2022 · CA
Analyses of the Molecular Functions for D-Cyclins
$461,278Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Mechanical Stress and Lung Tumor Progression
$461,181Jeffrey A. Weiss · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
LKB1/AMPK Signaling and Peutz-Jeghers Syndrome
$461,147Lewis C Cantley · Brigham And Women'S Hospital · P01 · FY2009 · CA
Regenerative function of myeloid derived suppressor cells in the damaged bone marrow endothelial niche
$461,132Kostandin Pajcini · University Of Illinois At Chicago · R01 · FY2025 · HL
A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules
$461,098Xin Meng · International Intelligent Infor/Solu/Lab · R44 · FY2019 · CA
Increasing Participation in Cancer Clinical Trials
$461,088Carol P Somkin · Kaiser Foundation Research Institute · R01 · FY2011 · CA
Rac guanine nucleotide exchange factors in lung cancer
$461,082Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2023 · CA
Targeting UHRF1 in combinational immunotherapy
$461,025Xiao-Fan Wang · Duke University · R01 · FY2023 · CA
Comparing Decision Makers: Theory and Implications for AI
$460,999Nikhil Agarwal · Massachusetts Institute Of Technology · · FY2025 · SBE
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$460,981Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2024 · CA
Epigenetic Stress and Chromate Carcinogenesis
$460,962Max Costa · New York University School Of Medicine · R01 · FY2022 · ES
Tumor Immune MicroEnvironment Facility
$460,935Wiem Lassoued · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Radiotherapeutic Nanoseeds for Internal Radiation Therapy of Unresectable Solid Tumors
$460,887Yaowu Hao · University Of Texas Arlington · R15 · FY2016 · CA
Harnessing beneficial off-target effects of kinase inhibitors in lung cancer
$460,844Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
Central mechanisms of glucocorticoid circadian rhythm dysfunction in breast cancer
$460,829Jeremy Borniger · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
Role of Formylpeptide Receptors in Host Defense
$460,819Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
The role of amphiregulin in mediating radiation cystitis in cancer survivors
$460,815Bernadette Margaretha Maria Zwaans · William Beaumont Hospital Research Inst · R01 · FY2025 · DK
Translating phospholipase activatable fluorophores for the sensitive detection of non-small cell lung cancer
$460,760Edward J Delikatny · University Of Pennsylvania · R01 · FY2023 · CA
Anticancer Agent Pharmacodynamics in Acute Leukemia
$460,757St. Jude Children'S Research Hospital · R01 · FY2002 · CA
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$460,702Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Project 1: PCBs: Metabolism, Genotoxicity and Gene Expression In Vivo
$460,603Larry W Robertson · University Of Iowa · P42 · FY2009 · ES